Integra LifeSciences promoted Glenn Coleman to COO and appointed Carrie Anderson CFO.
The medical technology company created the COO role after extreme growth. "Having doubled the size of our business over the past several years and nearly completing the transformational Codman acquisition integration, we have reached a critical inflection in Integra's history," said Peter Arduini, president and CEO of Integra LifeSciences. "Looking at the opportunities ahead, the creation of the COO role will provide the oversight we need to accelerate our future growth."
Mr. Coleman previously served as CFO and corporate vice president, overseeing the company's international business, financial reporting, accounting and budgeting. He also was responsible for Integra's investor relations and IT. He has previous experience in financial management and leading global businesses such as Curtiss-Wright.
In his new role, Mr. Coleman will oversee the company's operations and around 60 percent of its talent force, including commercial, clinical, research and development. With the new leadership structure, the company hopes to scale and expand globally.
"The move will also allow me to focus greater attention on our long-term strategic direction and spend more time with our customers," said Mr. Arduini.
The changes took effect June 24. As the new CFO, Ms. Anderson is responsible for accounting and financial reporting in addition to other financial duties. She has experience in global finance, acquisitions and divestitures as well as manufacturing and engineering.
"Carrie brings a dynamic set of experiences acquired over two decades working for large, multinational Fortune 500 companies," said Mr. Arduini. "She has worked globally across multiple industries and end-markets and has a proven track record of developing and executing finance organization strategy and solving complex business issues."